Quantbot Technologies’s PAVmed PAVM Stock Holding History

Quantbot Technologies’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	-$5K	–	2019
2022 Q1	$5K	Buy	+9	New	+$6.69K	﹤0.01%	1528
2021 Q4	–	Sell	-10	Closed	-$37K	–	1808
2021 Q3	$37K	Buy	10 +3	+43%	+$9.46K	﹤0.01%	1165
2021 Q2	$19K	Buy	+7	New	+$16.5K	﹤0.01%	1227

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantbot Technologies's PAVM Position: Q2 2022 in Review

Quantbot Technologies sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 9 shares — an estimated $5K sold.

Quantbot Technologies first reported a position in PAVM in Q2 2021 and held it in 3 quarters. The position peaked at $37K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

Quantbot Technologies reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
Quantbot Technologies sold 9 PAVmed shares in Q2 2022, an estimated $5K.
Quantbot Technologies first reported a position in PAVmed in Q2 2021 and held it in 3 quarters.
Quantbot Technologies's PAVmed position peaked at $37K in Q3 2021.
73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.